Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen, Nancy L. Bartlett, Jianyong Li, David Simpson, Sebastian Grosicki, Stephen Devereux, Helen O. McCarthy, Steven Coutré, Hang Quach, Gianluca Gaïdano, Zvenyslava Maslyak, Don A. Stevens, Ann Janssens, Fritz Offner, Jiřı́ Mayer, Michael O’Dwyer, Andrzej Hellmann, Anna Schuh, Tanya Siddiqi, Aaron Polliack, Constantine S. Tam, Deepali Suri, Mei Cheng, Fong Clow, Lori Styles, Danelle F. James, Thomas J. Kipps

New England Journal of Medicine, 2015

The University of Texas MD Anderson Cancer Center, Vita-Salute San Raffaele University, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Rochester, Medical University of Lodz, Copernicus Memorial Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Rabin Medical Center, Tel Aviv University, Washington University in St. Louis, Jiangsu Province Hospital, North Shore Hospital, Medical University of Silesia, King's College - North Carolina, King's College Hospital, Royal Bournemouth Hospital, Stanford University, St Vincent's Hospital Melbourne, The University of Melbourne, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, Norton Healthcare, Ghent University Hospital, University Hospital Brno, University Hospital Galway, Gdańsk Medical University, University of Oxford, City Of Hope National Medical Center, Hadassah Medical Center, Peter MacCallum Cancer Centre, Pharmacyclics (United States), University of California San Diego

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

1541

Citations

View on Google Scholar

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Abstract

Journal Details

Join JournalsHub

Welcome Back